Cleaved thioredoxin fusion protein enables the crystallization of poorly soluble ERalpha in complex with synthetic ligands.

Vincent Cura (1) , Monique Gangloff (2) , Sylvia Eiler (1) , Dino Moras (1) , Marc Ruff (1)

1 IGBMC - Institut de génétique et biologie moléculaire et cellulaire
2 Dpt Biochemistry

The ligand-binding domain (LBD) of human oestrogen receptor alpha was produced in Escherichia coli as a cleavable thioredoxin (Trx) fusion in order to improve solubility. Crystallization trials with either cleaved and purified LBD or with the purified fusion protein both failed to produce crystals. In another attempt, Trx was not removed from the LBD after endoproteolytic cleavage and its presence promoted nucleation and subsequent crystal growth, which allowed the structure determination of two different LBD-ligand-coactivator peptide complexes at 2.3 A resolution. This technique is likely to be applicable to other low-solubility proteins.

Domaines: Biologie moléculaire

Vincent Cura, Monique Gangloff, Sylvia Eiler, Dino Moras, Marc Ruff. Cleaved thioredoxin fusion protein enables the crystallization of poorly soluble ERalpha in complex with synthetic ligands.. Acta crystallographica Section F : Structural biology communications [2014-..], 2008, 64 (Pt 1), pp.54-7. ⟨10.1107/S1744309107066444⟩. ⟨hal-00264407⟩